Skip to main content

Table 1 Demographic Characteristics of Survey Participants

From: “Queer people are excellent caregivers, but we’re stretched so very thin”: Psychosocial wellbeing and impacts of caregiving among LGBTQI cancer carers

Demographic/ Cancer Characteristic

Carers

Patients cared for by carers

 

N

M (SD), range

N

M (SD), range

Age at time of study (years)

129

50.2 (17.2), 15-76

Age at diagnosis (years)

123

42.6 (16.7), 0-70

118

50.5 (15.2), 1-92

 

N

n (%)

N

n (%)

Country

129

 

 Australia

 

91 (70.5%)

  

 United States of America

 

14 (10.9%)

  

 United Kingdom

 

8 (6.2%)

  

 New Zealand

 

6 (4.7%)

  

 Canada

 

4 (3.1%)

  

 Othera

 

6 (4.7%)

  

Gender

129

 

129

 

 Cis female

 

80 (62.0%)

 

88 (68.2%)

 Cis male

 

26 (20.2%)

 

35 (27.1%)

 Transb

 

23 (17.8%)

 

4 (3.1%)

 Multiple PWCs with different identities

 

 

2 (1.6%)

Sexuality

129

 

129

 

 Lesbian, gay or homosexual

 

95 (73.6%)

 

79 (61.2%)

 Bisexual or pansexual

 

17 (13.2%)

 

5 (3.9%)

 Queer

 

12 (9.3%)

 

5 (3.9%)

 Straight or heterosexual

 

2 (1.6%)

 

33 (25.6%)

 Different or multiple identities

 

3 (2.3%)

 

1 (0.8%)

 Not sure

 

 

6 (4.7%)

Intersex variation

129

 

129

 

 Yes

 

5 (3.9%)

 

0

 No

 

124 (96.1%)

 

124 (96.1%)

 Prefer not to answer

 

0

 

0

 Not sure

 

 

5 (3.0%)

Race/ethnicity

129

 

 Caucasian

 

106 (82.2%)

  

 Asian

 

5 (3.9%)

  

 Australian Aboriginal, Torres Strait Islander or Maori

 

4 (3.1%)

  

 Mixed background

 

6 (4.7%)

  

 Other/unclear backgroundc

 

8 (6.2%)

  

Education

128

 

 Less than secondary

 

7 (5.5%)

  

 Secondary

 

17 (13.3%)

  

 Some post-secondary

 

9 (7.0%)

  

 Post-secondary

 

95 (74.2%)

  

Location

129

 

 Urban

 

66 (51.2%)

  

 Regional

 

48 (37.2%)

  

 Rural or remote

 

15 (11.6%)

  

Relationship to patient

129

 

 Partner/ex-partner

 

84 (65.1%)

  

 Family

 

31 (24.0%)

  

 Friend

 

11 (8.5%)

  

 Different relationship

 

1 (0.8%)

  

 Multiple patients/relationships

 

2 (1.6%)

  

Provided care during

125

 

 Intervention for cancer risk

 

30 (24.0%)

  

 Diagnosis

 

96 (76.8%)

  

 Curative treatment

 

91 (72.8%)

  

 Survivorship/follow-up care

 

72 (57.6%)

  

 Palliative/end-of-life care

 

48 (38.4%)

  

Care provided

125

 

 Emotional

 

125 (100.0%)

  

 Practical

 

109 (87.2%)

  

 Informational

 

80 (64.0%)

  

 Physical

 

77 (59.7%)

  

 Financial

 

50 (38.8%)

  

 Spiritual

 

37 (28.7%)

  

Other responsibilities

125

 

 Household responsibilities

 

105 (84.0%)

  

 Work/volunteering

 

38 (30.4%)

  

 Other caregiving

 

22 (17.6%)

  

 Dependent children

 

16 (12.8%)

  

Cancer diagnosis (first)

126

 

 Brain

   

9 (7.1%)

 Breast

   

37 (29.4%)

 Cervical

   

3 (2.4%)

 Colorectal

   

8 (6.3%)

 Head/neck

   

10 (7.9%)

 Leukaemia

   

5 (4.0%)

 Lung

   

7 (5.6%)

 Lymphoma

   

6 (4.8%)

 Ovarian

   

13 (10.3%)

 Prostate

   

7 (5.6%)

 Skin

   

3 (2.4%)

 Uterine

   

4 (3.2%)

 Otherd

   

11 (8.7%)

 Not sure or unknown

   

3 (2.4%)

Cancer stage

126

 

 Localised

   

53 (42.1%)

 Regional

   

42 (33.3%)

 Distant/metastatic

   

23 (18.3%)

 N/A (e.g. blood cancer)

   

1 (0.8%)

 Not sure or unclear

   

7 (5.6%)

Subsequent cancerse

126

 

 ecurrence

   

30 (23.3%)

 New primary cancer

   

19 (14.7%)

Treatment status

126

 

 No treatment yet

   

5 (3.9%)

 On active curative treatment

   

12 (9.4%)

 On maintenance treatment

   

19 (15.0%)

 In remission/completed treatment

   

35 (27.6%)

 Receiving palliative care (no further active treatment)

   

2 (1.6%)

 Deceased

   

51 (40.2%)

 Not sure, unclear, or multiple

   

3 (2.4%)

  1. aBelize (n = 2), Argentina, Lebanon, Germany, Uganda (n = 1 each)
  2. b16 (12.4%) non-binary, 5 (3.9%) trans female, 2 (1.6%) trans male; patients: 2 (1.5%) non-binary, 1 (0.8%) trans female, 0 trans male, 3 (2.3%) different or multiple identities
  3. cHispanic/Latine, Jewish (n = 2 each), African, Native American (n = 1 each), not clearly described (n = 2)
  4. dBladder, liver, pancreatic (n = 2 each), kidney, mesothelioma, pseudo myxoma perotini, stomach, thymus (n = 1 each)
  5. eRespondents could select multiple if applicable